Cited by 637Vitamin C and Antioxidants ResearchComplementary and Alternative Medicine StudiesAntioxidant Activity and Oxidative Stress

High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy: A Randomized Double-Blind Comparison

Moertel, Charles G., Fleming, Thomas R., Creagan, Edward T., Rubin, Joseph, O'Connell, Michael J., Ames, Matthew M.·1985·New England Journal of Medicine

Abstract

It has been claimed that high-dose vitamin C is beneficial in the treatment of patients with advanced cancer, especially patients who have had no prior chemotherapy. In a double-blind study 100 patients with advanced colorectal cancer were randomly assigned to treatment with either high-dose vitamin C (10 g daily) or placebo. Overall, these patients were in very good general condition, with minimal symptoms. None had received any previous treatment with cytotoxic drugs. Vitamin C therapy showed no advantage over placebo therapy with regard to either the interval between the beginning of treatment and disease progression or patient survival. Among patients with measurable disease, none had objective improvement. On the basis of this and our previous randomized study, it can be concluded that high-dose vitamin C therapy is not effective against advanced malignant disease regardless of whether the patient has had any prior chemotherapy.

Integrity signals

Registry

Crossref · 10.1056/nejm198501173120301

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some clinical trials with high doses of vitamin C failed to show a benefit in cancer patients because vitamin C was administered orally in these studies.

    “Some clinical trials with high doses of vitamin C failed to show a benefit in cancer patients because vitamin C was administered orally in these studies [154,178,179].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O'Connell, M. J., & Ames, M. M.
Affiliations
Mayo Clinic (US)
Venue
New England Journal of Medicine
Published
1985-01-17
Volume
312
Issue
3
Pages
137-141
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2332542469
Cited by
637
References
7
Citations by year
2026: 19 · 2025: 18 · 2024: 20 · 2023: 20 · 2022: 32 · 2021: 35 · 2020: 28 · 2019: 23 · 2018: 30 · 2017: 28 · 2016: 22 · 2015: 22 · 2014: 20 · 2013: 24 · 2012: 17
FWCI
17.73
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (CA31224, CA 00755)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
Keywords
high-dose vitamin C, vitamin C, advanced colorectal cancer, advanced cancer, disease progression, survival, treatment efficacy
MeSH terms
Aged, Ascorbic Acid, Clinical Trials as Topic, Colonic Neoplasms, Double-Blind Method, Female, Humans, Male, Middle Aged, Patient Compliance, Prospective Studies, Random Allocation, Rectal Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review